Management of periprocedural anticoagulant therapy: a novel individualized approach—a transeusophageal echocardiographic study-Reference-Cited by-同舟云学术

Management of periprocedural anticoagulant therapy: a novel individualized approach—a transeusophageal echocardiographic study

Published:2020-04-13 Issue:2 Volume:50 Page:408-415
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Durmaz Eser,Karadag Bilgehan,İkitimur Baris,Ebren Cansu,Tokdil Hasan,Koca Damla,Ozmen Emre,Polat Fuat,Ohtaroglu Tokdil Kardelen,Raimoglu Utku,Mutlu Deniz,Atici Adem,Ongen Zeki

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

https://link.springer.com/content/pdf/10.1007/s11239-020-02104-9.pdf

Reference23 articles.

1. Kirchhof P, Benussi S, Kotecha D et al (2016) 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893–2962

2. January CT, Wann LS, Alpert JS et al (2014) 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol 64:e1–e76

3. Ezekowitz MD, Pollack CV, Sanders P, Halperin JL, Spahr J, Cater N, Petkun W, Breazna A, Kirchhof P, Oldgren J (2016) Apixaban compared with parenteral heparin and/or vitamin K antagonist in patients with nonvalvular atrial fibrillation undergoing cardioversion: rationale and design of the EMANATE trial. Am Heart J 179:59–68

4. Healey JS, Eikelboom J, Douketis J et al (2012) Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin. Circulation 126:343–348

5. Yong JW, Yang LX, Ohene BE, Zhou YJ, Wang ZJ (2017) Periprocedural heparin bridging in patients receiving oral anticoagulation: a systematic review and meta-analysis. BMC Cardiovasc Disord 17:295